Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Last night's topic of using LL as a regular drug r

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154704
(Total Views: 508)
Posted On: 12/14/2023 9:39:14 AM
Posted By: SamaGong
Last night's topic of using LL as a regular drug rubs salt in my new open wound. Grouchy me says a loud f u to discussions about 'the market' wanting/demanding a longer acting version of LL. Screwest thyself as thou also screwest others.

Bob Newhart did great stand up comedy. So I'll cast him as the doc taking a phone call from a patient.
Briefly:

Yes, hello Mrs. Smith. I'm calling you back about your triple negative breast cancer treatment question. You're right, we could use LL, but we're waiting while they finish inventing/developing/perfecting/trialing/ducks-in-a-rowing the longer acting version so you'd only have to do your subQ injection once per month.

And so I think it's best if ... What's that? Yes, subcutaneous injection, that's what I said. Yes, yes, that's right, just like your husband uses for his sugar ... Yes, I'm aware he injects several times per day, but... What? Yes, I'm not surprised it's painless for him. Most patients say that.

So anyway ... Leronlimab is safe and was tested as once per week subQ injection with great receptor occupancy. What's that? Why can't you just do what? Oh, use LL once per week? Well right, but big pharma says people want ... Well, no Mrs. Smith, I don't know if those people have TNBC ... Yes, I agree it makes sense to go once weekly, but it's not available or approved ...Yes, yes, I know it's your life we're talking about.

No, no, I don't know how many weeks or months you have left, although I think LL looks very promising. And ... What? Well, you can say that to them if you want, but honestly, I might lose my job if I said that ... What? Personal injury attorney? Not a bad idea. Goodbye, Mrs. Smith. And Good Luck.


(10)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us